Cellular immune system defense against the invasion of viruses and tumors depends on the presentation of peptides at the cell surface for recognition by cytotoxic T lymphocytes (1) . These peptides must be bound by cell surface class I major histocompatibility complex (MHC) 1 heavy chains. Assembly of the MHC class I heavy chain, a light chain called ␤ 2 -microglobulin (␤ 2 m), and peptide into the heterotrimeric, complete MHC class I molecule occurs in the endoplasmic reticulum (ER) (2, 3) . ER resident proteins such as calreticulin, the transporter associated with antigen processing (TAP), tapasin, and ERp57 interact with peptide-free class I heavy chain/␤ 2 m to assist with peptide binding (4 -11) .
Although many aspects of chaperone assistance with the folding of class I molecules have been elucidated, the rules governing chaperone selection have not been fully defined. It has been shown that the products of certain class I alleles may interact disparately with different chaperones. Natural HLA molecules with limited amino acid changes in the ␣2 domain differ in respect to whether they associate with TAP (12) . Certain HLA-A and -B subtypes strongly associate with TAP, tapasin, and calreticulin, while others differing only at a single amino acid residue show little to no association with these same proteins (13) (14) (15) . Furthermore, the HLA subtypes that lack association with these ER proteins are more poorly retained and are present in greater quantity at the cell surface, indicating that differences in the ability of natural MHC heavy chains to interact with these ER proteins are functionally relevant (13) (14) (15) .
Amyloid precursor-like protein 2 (APLP2) is a type I transmembrane protein and a member of the amyloid precursor protein family that is implicated in the etiology of Alzheimer's disease; however, APLP2 lacks the ␤-amyloid peptide domain (〈␤) that is deposited as extracellular amyloid in the brain parenchyma of Alzheimer's disease patients (16, 17) . Although APLP2 is ubiquitously expressed, its function is unknown. In the ER, APLP2 associates with the murine class I MHC molecule K d and with some HLA molecules (18 (26) . These cell lines were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented as described above with the addition of 0.2 mg/ml Geneticin (Invitrogen) or 0.2 mg/ml Geneticin and 0.1 mg/ml hygromycin B (Calbiochem), respectively. All cells were maintained at 37°C in 5% CO 2 .
Antibodies-⌻he mAb 64-3-7 is an IgG2 Ab that recognizes a short stretch of amino acids in the ␣1 domain of open, peptide-free L d (27, 28) . The mAb 34-1-2 is directed against the ␣1/␣2 domain of folded, peptideoccupied K d (29) . SF1. (33, 34) . Generation of the polyclonal rabbit antisera AP 206 and AP tail has been described previously (18) . Briefly, rabbits were immunized with peptides representing amino acids 206 -219 of APLP2 (for AP 206) or corresponding to the C terminus of APLP2 (for AP tail). AP 206 recognizes human APLP2, while AP tail cross-reacts with both human and murine APLP2. Although the AP 206 serum is specific for APLP2, the AP tail serum also binds to amyloid precursor protein at a very low level (18) . Since the AP tail serum reacted much better with APLP2 than did AP 206 and because co-precipitation of endogenous amyloid precursor protein using the AP tail serum was at a negligible level, the AP tail serum was used for some experiments.
Mutagenesis and Transfection-The etK d cDNA was generated by site-directed mutagenesis at position 48 (arginine 3 glutamine) using the QuikChange mutagenesis kit from Stratagene Cloning Systems (La Jolla, CA) as described previously (20) . This substitution confers the epitope for the 64-3-7 mAb. The etK d has been thoroughly tested for proper assembly, folding, and trafficking and shown to function equivalently to wild type K d (20) . Infection with Recombinant Adenovirus-The adenoviral vectors used had deletions of the E1 and E3 regions of the adenovirus, and a dual expression cassette was inserted in place of the E1 region (35) . The expression cassette carries E3/19K driven by the cytomegalovirus promoter with or without the reporter gene ␤-glucuronidase driven from the Rous sarcoma virus promoter. ␤-Glucuronidase expression allows the assessment of infection efficiency by immunohistochemistry. The null control vector has the E3/19K sequence deleted. For infections, untransfected HeLa cells and HeLa-etK d cells (1 ϫ 10 7 of each) were plated and infected 24 h later in 3 ml of serum-free medium at a multiplicity of infection of 20 for 2 h at 37°C. The virus was then washed off the cells with phosphate-buffered saline (PBS), and medium with serum was added. Twenty-four hours later, the cells were washed two times with PBS. Radiolabeling and immunoprecipitations were then carried out as described below.
Metabolic Labeling, Immunoprecipitation, and Western BlottingCells were preincubated for 30 min at 37°C in methionine-free culture medium. For each immunoprecipitation, 1 ϫ 10 7 cells were used. The cells that were compared within each experiment were of matched, high viability and of matched confluence. Next [ 35 S]methionine (100 Ci/ml) was added, and the cells were radiolabeled for 30 min. The cells were then washed three times in PBS containing iodoacetamide (Sigma) and lysed in 1% CHAPS (Roche Molecular Biochemicals) or 1% digitonin in Tris-buffered saline (pH 7.4) with freshly added 0.2 mM phenylmethylsulfonyl fluoride (Sigma) and 20 mM iodoacetamide. L-1-Chloro-3-(4-tosylamido)-7-amino-2-heptanone hydrochloride (Roche Molecular Biochemicals) was also added to the digitonin lysis buffer. The lysis buffer was supplemented with a saturating volume of mAb before its addition to pelleted cells. After incubation for 1 h on ice, nuclei were removed by centrifugation, and lysates were incubated with protein A-Sepharose beads (Amersham Biosciences). The beads were washed three times with ice-cold 0.1% CHAPS or 0.1% digitonin in Tris-buffered saline (pH 7.4), and protein was eluted from the beads by boiling in 0.125 M Tris (pH 6.8), 0.2% SDS, 12% glycerol, 2% bromphenol blue. All immunoprecipitates were electrophoresed on 4 -20% Tris-glycine acrylamide gels (Invitrogen). In instances where comparisons were made, all samples were electrophoresed on the same gel. For autoradiographs, gels were soaked in Amplify (Amersham Biosciences) plus 2% glycerol, dried, and exposed to Biomax MR film (Eastman Kodak Co.).
For Western blotting, immunoprecipitates were electrophoresed by SDS-PAGE as described above and were transferred to Immobilon-P membranes (Millipore, Bedford, MA). After blocking overnight at 4°C in 10% (w/v) dry milk, 0.05% Tween 20 in PBS, membranes were incubated in a dilution of Ab for 2 h, washed three times with 0.05% Tween 20 in PBS, and incubated for 1 h with biotin-conjugated goat anti-rabbit IgG (Caltag Laboratories, San Francisco, CA). Following three washes with 0.05% Tween 20 in PBS, membranes were incubated for 1 h with streptavidin-conjugated horseradish peroxidase (Zymed Laboratories Inc., San Francisco, CA), washed three times with 0.3% Tween 20 in PBS, and incubated with enhanced chemiluminescence Western blot developing reagents (Amersham Biosciences). Membranes were exposed to Biomax MR film for various periods of time.
Reverse Transcription-PCR-RNA was prepared from 4 ϫ 10 6 DAP-3 L cell fibroblasts by the Qiagen RNeasy minikit. The reverse transcription-PCR was performed with the Gene-Amp kit (Applied Biosystems, Branchburg, NJ) using primers designed with APLP2-specific sequences (5Ј-ACCAATGATGTTGATGTGTATTTT-3Ј and 5Ј-TAAGGAA-CTTTGTACAGAAGAGA-3Ј).
Flow Cytometry-Cells were centrifuged and resuspended at 5 ϫ 10 6 /ml in PBS containing FACS medium (0.2% bovine serum albumin, 0.1% sodium azide). Cell suspension aliquots (0.1 ml) were added to a 96-well plate. The cells were incubated with saturating concentrations of antibody or FACS medium alone for 30 min at 4°C, washed two times, and incubated with phycoerythrin-conjugated, Fc-specific, affinity-purified F(abЈ) 2 fragment of donkey anti-rabbit IgG (if AP 206 had been used as the primary Ab) or goat anti-mouse IgG (if 34-1-2 had been used as the primary Ab) for 30 min at 4°C. The cells were then washed two times, resuspended, and analyzed on a FACS-Calibur flow cytometer (BD Immunocytometry Systems) at the University of Nebraska Medical Center Cell Analysis Facility.
Treatment with APLP2-specific Short Interfering RNA (siRNA)-RNA interference treatments were performed using an established technique (36) . The duplex siRNA and inverse siRNA used were obtained from Dharmacon Research, Inc. (Lafayette, CO) in the annealed and purified form. The APLP2 siRNA sense sequence used was 5Ј-GTTCTTCAGTACTGTCAGGdTdT-3Ј. This sequence corresponds to an APLP2 sequence that follows an AA plus it has two dT residues added to the 3Ј-end of the RNA. The APLP2 inverse siRNA sense sequence used was 5Ј-GGACTGTCATGACTTCTTGdTdT-3Ј. In the design of the siRNA, a National Center for Biotechnology Information data base BLAST search was performed to ensure that the siRNA would target only APLP2.
For each duplex, 20 nmol of purified, annealed duplex in annealing buffer was received from Dharmacon Research, Inc. to which we added 1 ml of RNase-free water (also supplied by Dharmacon Research, Inc.) to make a 20 M stock solution. The day prior to transfection, HeLaetK d cells were plated in six-well plates at 1 ϫ 10 5 cells/well in 3 ml of antibiotic-free medium per well. After overnight incubation at 37°C in 5% CO 2 , the cells were transfected as follows. For each well, 12 l of Oligofectamine (Invitrogen) and 3 l of Opti-MEM (Invitrogen) were combined in a polystyrene tube, mixed gently without vortexing, and incubated for exactly 5 min at room temperature. In separate tubes, the siRNA or inverse siRNA was diluted as follows. For each well of a six-well plate, 175 l of Opti-MEM was mixed with 10 l of duplexed 20 M siRNA, inverse duplexed 20 M siRNA, or water. For each well, diluted Oligofectamine solution (15-l total volume) was combined with diluted siRNA solution (185-l total volume) in a polystyrene tube, mixed gently by pipetting, and incubated 15 min at room temperature. The plates were then incubated at 37°C in 5% CO 2 . were present in the cell lysates (Fig. 2) ; however, no association was found between APLP2 and open K d . Thus APLP2 recognizes a conformational binding site in the ␣1/␣2 region.
RESULTS

APLP2
Two bands, migrating closely to each other, are visible in the 64-3-7 lane in Fig. 2 . The identity of the upper band in the doublet is not known for certain. It may be a differentially glycosylated form of etK d , or it may be tapasin, which has a molecular weight slightly larger than that of the MHC class I heavy chain and which associates with open MHC class I heavy chains, including 64-3-7 ϩ etK d (8, 10, 37, 38) . Two bands have previously been distinguished in autoradiographs of 64-3-7 immunoprecipitates of L d and etK d (7, 38) . Interestingly the higher molecular weight band is not visible in the SF1.1.1 lane in Fig. 2 FACS medium alone. Following incubation with fluorescently labeled secondary antibody, the cells were analyzed by flow cytometry. APLP2 was detected at equivalent levels on HeLa and HeLa-etK d (Fig. 3) is known to bind to class I molecules and retain them in the ER through an ER retrieval sequence in its cytoplasmic tail (21, 44, 45) . E3/19K also binds independently to TAP and thereby prevents tapasin from bridging TAP to class I (46) . We found that the association of APLP2 with etK d increased when HeLa-etK d cells expressed E3/19K (Fig.  4) , consistent with a similar observation by Sester et al. (18) .
Since the binding of APLP2 to etK d was limited to the folded form of etK d (Fig. 2) , we tested whether binding of E3/19K was similarly restricted. APLP2-specific siRNA, but not mock or inverse siRNA, significantly down-regulated APLP2 intracellular expression by 3 and 4 days post-treatment (Fig. 6) . The down-regulation in APLP2 expression was accompanied by a relative increase in cell surface etK d expression ( Fig. 7 and Table I ). Similar results were obtained with 34-1-2 and with SF1.1.1 in three separate experiments. APLP2 seems to retain etK d and depress its surface expression, supporting a possible role for APLP2 in regulating the trafficking of K d out of the ER. Thus APLP2, a secreted protein, may regulate ER/Golgi export of K d . Considering our results with APLP2-specific siRNA (Fig. 7 and Table I etK d (Fig. 1) . Our findings suggest that a cell-specific factor might be involved in the interaction between K d and APLP2. Another possibility is that the difference is related to the presence of human versus murine ␤ 2 m in these two cell types since ␤ 2 m is a requirement for APLP2/K d interaction (18 A new model for K d assembly that incorporates APLP2 would include interaction of K d with calnexin, association of the peptide-free heavy chain with tapasin, calreticulin, ERp57, and TAP, and then release of these proteins and interaction with APLP2 prior to peptide binding and migration to the cell surface. Since it has been shown that K d interacts with glycosaminoglycan-modified APLP2, which is created in the Golgi (18), then K d ⅐APLP2 complexes presumably exist beyond the ER. Interestingly the exit of MHC class I molecules from the ER has recently been shown to be regulated at a point subsequent to TAP binding (47) . Our results demonstrate that some APLP2 molecules are present even at the surface of HeLa and HeLaetK d cells (Fig. 3) . Our results show that the presence of the adenoviral protein E3/19K results in increased association of APLP2 with etK d . The E3/19K protein, like APLP2, seems to bind preferentially to the folded form of K d (Fig. 5) , indicating that it also has specificity for a conformational determinant. Similarly, when we immunoprecipitated folded forms of the endogenous HLA class I molecules present in 293-E3/19K cells with mAb W6/32, E3/19K was co-precipitated; in contrast, HC10 immunoprecipitates of open HLA class I molecules did not contain associated E3/19K (data not shown).
Viruses are known to use numerous mechanisms to evade recognition by the immune system, and it is possible that the adenovirus recruits APLP2 for its benefit. Our finding that APLP2 reduces the level of cell surface etK d is consistent with this notion. Adenovirus E3/19K down-regulates class I expression by direct retention of class I (21, 44, 45) and by binding to TAP (46) . By retaining APLP2 in the ER, E3/19K may be acting to reduce K d expression further. This would be a third mechanism whereby this single adenoviral protein down-regulates the surface expression of the MHC class I molecule.
Although APLP2 binds well to K d , it does not bind to all MHC class I molecules (18, 19) . This attribute is not unique to APLP2 since MHC class I allele specificity is also exhibited by TAP, tapasin, and calreticulin (12) (13) (14) (15) . Disparity among class I molecules in regard to chaperone dependence may provide protection against attack from viruses against any particular chaperone. In this case, if adenovirus is indeed using APLP2 to increase the down-regulation of K d , the inability of APLP2 to interact with all class I molecules limits the extent to which APLP2 can be exploited by the virus. 
